REGISTERED
on 09 Jan 2024
Last Applicant/ Owned by
1700 OWENS ST.
SAN FRANCISCO
CA
94158
Serial Number
90016459 filed on 23rd Jun 2020
Registration Number
7270000 registered on 09th Jan 2024
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
TALLAC THERAPEUTICS
Pharmaceuticals in the field of immune cell activation with toll-like receptor agonist antibody-conjugates (TRAAC), namely, pharmaceuticals for the treatment and prevention of immune system related diseases and disorders, inflammatory diseases and disorders, autoimmune diseases and disorders, and cancer
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceuticals in the field of immune cell activation with toll-like receptor agonist antibody-conjugates (TRAAC), namely, pharmaceuticals for the treatment and prevention of immune system related diseases and disorders, inflammatory diseases and disorders, autoimmune diseases and disorders, and cancer
First Use Date in General
11th Sep 2023
First Use Date in Commerce
11th Sep 2023
Mark Details
Serial Number
No 90016459
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 144960314271
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 09th Jan 2024 | REGISTERED-PRINCIPAL REGISTER |
| 09th Jan 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 07th Dec 2023 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 06th Dec 2023 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 15th Nov 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 14th Nov 2023 | SOU EXTENSION 5 GRANTED |
| 14th Nov 2023 | STATEMENT OF USE PROCESSING COMPLETE |
| 09th Nov 2023 | TEAS STATEMENT OF USE RECEIVED |
| 09th Nov 2023 | SOU TEAS EXTENSION RECEIVED |
| 09th Nov 2023 | SOU EXTENSION 5 FILED |